Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

Studying Endogenous Protein Dynamics with CRISPR-Mediated Tagging: Understanding Your Options

Topics include:

  • An efficient, cloning-free method for knock-in of HiBiT and other protein tags
  • How these endogenously modified cells can be used in a variety of assay formats
  • Do-it-yourself approaches, the availability of pools and stable clones, and support for assay development

 

Summary

CRISPR/Cas9 technology has revolutionized genome editing by offering a simple method to tag proteins at endogenous loci, facilitating the study of protein biology while maintaining proper transcriptional regulation, expression levels and stoichiometry with binding partners.  By contrast, ectopic expression of tagged proteins can lead to a variety of overexpression artifacts, like mislocalization, aggregation or dysregulation of degradation.  HiBiT, an 11-amino-acid bioluminescent peptide, represents an ideal tag for endogenous labeling due to its small size and large, linear dynamic range. 

In this webinar, we will highlight an efficient, cloning-free method for knock-in of HiBiT, as well as other protein tags, and we will discuss how these endogenously modified cells can be used in a variety of assay formats to study protein abundance, localization, modification and interactions.  Additionally, we will discuss do-it-yourself approaches, the availability of pools and stable clones, and support for assay development.


Speaker

chris-eggers-125x125

Christopher Eggers, PhD
Senior Research Scientist

Dr. Christopher Eggers received his Ph.D. in biochemistry and molecular biology from the University of California at San Francisco and then completed a postdoctoral fellowship at the Howard Hughes Medical Institute at UC San Diego. Since 2011, Dr. Eggers has been a Senior Research Scientist at Promega, where he has focused principally on the development of the NanoLuc® and NanoBiT® technologies to create new bioluminescent assays that simplify the measurement of protein dynamics.

We love to talk science.

Sign up to receive monthly invitations to our webinars.

Sign Up